Category:
Prophylactic Biological Products
CAS NO:
204656-20-2
Standard:
ChP,USP,
Indications:
Mechanism of Action: Liraglutide mimics the action of the endogenous hormone GLP-1, which enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon secretion, delays gastric emptying, and reduces appetite and food intake.
Pharmacokinetics:
Form: Liraglutide API is typically found as a clear and colorless solution or as a white lyophilized powder.